Literature DB >> 29757463

Depression-related behavioural and neuroendocrine changes in the Spontaneously Diabetic Torii (SDT) fatty rat, an animal model of type 2 diabetes mellitus.

Katsuya Sakimura1, Tatsuya Maekawa1, Kazuo Sasagawa1, Yukihito Ishii1, Shin-Ichi Kume2, Takeshi Ohta1.   

Abstract

Depression is one of the most common psychiatric diseases and is commonly comorbid with type 1 or 2 diabetes mellitus (DM). However, the pathophysiology underlying the depressive state in DM remains poorly understood. Animal models are useful tools to investigate the association between depression and DM. In the present study we investigated whether the Spontaneously Diabetic Torii (SDT) fatty rat, a novel animal model of type 2 DM, shows depression-related features. We assessed depression-like behaviour, hyperactivation of the hypothalamic-pituitary-adrenal (HPA) axis, and neurotransmitter levels in the brain. Behaviour was evaluated using a forced swimming test, and the HPA axis was evaluated with changes in plasma corticosterone levels after a swimming stress exposure or dexamethasone challenge. In addition, serotonin (5-hydroxytryptamine; 5-HT), noradrenaline, glutamate and γ-aminobutyric acid (GABA) concentrations in the frontal cortex, hippocampus and brain stem were measured. In the forced swimming test, SDT fatty rats exhibited increased duration of immobility compared with control Sprague-Dawley (SD) rats. Moreover, basal corticosterone levels were significantly elevated in SDT fatty compared with control SD rats. However, there were no stress-induced increases or changes in dexamethasone-induced suppression of corticosterone in SDT fatty compared with control SD rats. Furthermore, there were significant changes in 5-HT concentrations in the prefrontal cortex, and in GABA and glutamate concentrations in the hippocampus in SDT fatty compared with controls. The results of the present study suggest that the SDT fatty rat may be an appropriate model for diabetes with comorbid depression associated with neurotransmitter impairments and aberrant basal HPA hyperactivity.
© 2018 John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  depressive disorder; diabetes type 2; neurotransmitter; stress and hormones

Year:  2018        PMID: 29757463     DOI: 10.1111/1440-1681.12965

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  4 in total

Review 1.  Function of the GABAergic System in Diabetic Encephalopathy.

Authors:  Hongli Zhou; Zhili Rao; Zuo Zhang; Jiyin Zhou
Journal:  Cell Mol Neurobiol       Date:  2022-04-23       Impact factor: 5.046

2.  Pathophysiological features in the brains of female Spontaneously Diabetic Torii (SDT) fatty rats.

Authors:  Tatsuya Maekawa; Miki Sugimoto; Shinichi Kume; Takeshi Ohta
Journal:  J Vet Med Sci       Date:  2022-01-27       Impact factor: 1.267

Review 3.  The serotonergic system dysfunction in diabetes mellitus.

Authors:  Yan Cai; Xiaolong Li; Hongli Zhou; Jiyin Zhou
Journal:  Front Cell Neurosci       Date:  2022-07-14       Impact factor: 6.147

4.  Pathophysiological abnormalities in the brains of Spontaneously Diabetic Torii-Lepr fa (SDT fatty) rats, a novel type 2 diabetic model.

Authors:  Tatsuya Maekawa; Takeshi Ohta; Shinichi Kume
Journal:  J Vet Med Sci       Date:  2018-07-17       Impact factor: 1.267

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.